Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
What to Look for Before Buying a Pharma Stock
There are many criteria for evaluating a pharmaceutical stock, but one of the easiest to start with is the drug pipeline. You can do so by looking at quarterly reports or listening to earnings calls, as companies tend to spotlight their most…
Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia's largest yet such offering this year. The company's shares fell. The Melbourne, Australia-based…
Hormuz crisis may push up drug prices: Pharma MSMEs battle cost spike of raw materials, packaging
Disruptions in shipping routes have sharply raised input costs and triggered supply uncertainties for India's small-scale pharmaceutical manufacturers, who warn of cascading effects on medicine prices, availability and even quality. Several key…
TheraNym Biologics, an arm of Aurobindo Pharma, expands scope of pact with Singapore firm MSD
: TheraNym Biologics, an arm of Aurobindo Pharma, will construct a greenfield project for commissioning a large scale mammalian drug substance manufacturing facility with an investment of around $150-$175 million. “This will be as per a new…
Govt enhances C3, C4 allocation for pharma, packaging chemical sectors to 1,000 tonnes/day
The Ministry of Petroleum and Natural Gas (MoPNG) said on Wednesday that it will now make available 1,000 tonnes per day (TPD) of C3 (propane) and C4 (butanes/ butenes) streams for critical sectors such as pharma, packaging, polymers, etc. The…
Pharmalittle: We're reading about FDA seeking more data on a Lilly obesity pill, a pharma 340B win, and more
Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we…
Watching A Potential Big Pharma Buyout
One trader that I've known for years and take seriously today pointed out a small-cap biotech flying under the radar that could wind up checking a lot of boxes that large pharmaceutical companies look for in an acquisition target: late-stage…
Foster Victor Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX
Foster Victor Wealth Advisors LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 180,657 shares of the biopharmaceutical…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Consensus Rating of 'Moderate Buy' from Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has earned an average recommendation of 'Moderate Buy' from the twelve analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a…
Athira Pharma (NASDAQ:LONA) Shares Down 6.5% - Should You Sell?
Shares of Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) traded down 6.5% during mid-day trading on Tuesday. The company traded as low as $9.06 and last traded at $9.07. 35,461 shares traded hands during trading, a decline of 51% from the…
Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Here's What Happened
Innate Pharma SA (OTCMKTS:IPHYF - Get Free Report)'s stock price rose 9.3% during trading on Tuesday. The stock traded as high as $1.50 and last traded at $1.50. Approximately 1,000 shares traded hands during mid-day trading, an increase of 19,900%…
neffy approved as the first needle-free anaphylaxis treatment of adults and children in Canada
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that Health Canada has approved neffy 2 mg for the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products and other allergens, as…
Jim Cramer's top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, April 15 1. Stock futures are basically flat this morning as the S & P 500 sits within spitting distance of a new record close. We've had a remarkable comeback rally from the late March lows, leading to an…
Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award
Tokyo, Japan and Cambridge, UK, 15 April 2026 – Nxera Pharma Co. Ltd (“Nxera” or the “Company”; TSE 4565) announces that, in connection with the introduction of the Employee Stock Ownership Plan for employees…
Novartis CEO joins Anthropic's board of directors
The appointment was made in accordance with Anthropic's specific governance structure, the Long-Term Benefit Trust, as announced by the US company on Tuesday night. This is an independent body overseeing Anthropic's long-term direction, designed to…
Receive a Daily briefing on Pharma Industry News
Get Started